Evidence map›Paper›PMID 37645516›Full record

ArticleFrontiers in cardiovascular medicine2023

Contemporary European practice in transcatheter aortic valve implantation: results from the 2022 European TAVI Pathway Registry.

Liesbeth Rosseel, Darren Mylotte, Bernard Cosyns, Maarten Vanhaverbeke, David Zweiker, Rui Campante Teles, Oskar Angerås, Antoinette Neylon, Tanja Katharina Rudolph, Joanna J Wykrzykowska and 18 more

Registry-linked trialAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06602609 (Remote Acute Monitoring-based Same-day Discharge Strategy of Post Transcatheter Aortic Valve Implantation Patients Versus Standard Care at 30-Day Follow-up), which is not on this map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06602609 narecruitingnot on this mapstarted 2024, after this paper: background citation

Remote Acute Monitoring-based Same-day Discharge Strategy of Post Transcatheter Aortic Valve Implantation Patients Versus Standard Care at 30-Day Follow-up

TypeinterventionalSponsorImperial College LondonRan2024 to 2028Enrolled216ConditionsAortic Valve Stenosis, Cardiac Conduction Disturbance, Digital Health, Transcatheter Aortic Valve ImplantationArmsRemote Patient Monitoring Strategy, Standard Medical Therapy
3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. The implementation of a streamlined TAVI patient pathway across five European countries: BENCHMARK registry.Clinical research in cardiology : official journal of the German Cardiac Society · 2026
    Observational
  3. Article
  4. Timely hospital discharge in TAVI patients: towards a patient-centered care pathway.Clinical research in cardiology : official journal of the German Cardiac Society · 2026
    Review
  5. Prognostic Impact of Frailty in Transcatheter Aortic Valve Implantation.Journal of cardiovascular development and disease · 2026
    Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Review
  11. Review
  12. Fighting time: the critical importance of pre-TAVR mortality risk prediction.Clinical research in cardiology : official journal of the German Cardiac Society · 2025
    Article
  13. Transcatheter aortic valve implantation without on-site surgical backup: is it time for Poland to embrace the paradigm shift?Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2025
    Article
  14. Review
  15. Review
  16. Development and validation of the D-PACE scoring system to predict delayed high-grade conduction disturbances after transcatheter aortic valve implantation.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2025
    Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Liesbeth RosseelDepartment of Cardiology, Algemeen Stedelijk Hospital, Aalst, Belgium.
Darren MylotteDepartment of Cardiology, University Hospital Galway and National University of Ireland, Galway, Ireland.
Bernard CosynsFaculteit Geneeskunde, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Maarten VanhaverbekeDepartment of Cardiology, AZ Delta, Roeselare, Belgium.
David ZweikerDivision of Cardiology, Department of Cardiology and Intensive Care, Clinic Ottakring, Medical University of Graz, Graz, Austria.
Rui Campante TelesCentro Hospitalar de Lisboa Ocidental (CHLO), Hospital de Santa Cruz.
Oskar AngeråsDepartment of Cardiology, Sahlgrenska University Hospital, Gothenberg, Sweden.
Antoinette NeylonInstitut Cardiovasculaire Paris Sud, Ramsay Santé, Massy, France.
Tanja Katharina RudolphClinic of General and Interventional Cardiology, Heart and Diabetes Center Nordrhine Westfalia, Ruhr-University, Bad Oeynhausen, Germany.
Joanna J WykrzykowskaDepartment of Cardiology, University Medical Center Groningen, Groningen, Netherlands.
Tiffany PattersonDepartment of Cardiology, Guys and St Thomas' NHS Foundation Trust London, London, United Kingdom.
Giulia CostaCardiac Catheterization Division, Cardiothoracic and Vascular Department, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
Soledad OjedaDivision of Interventional Cardiology, Reina Sofia Hospital, Maimonides Institute for Research in Biomedicine of Córdoba (IMIBIV), University of Córdoba, Córdoba, Spain.
Apostolos TzikasDepartment of Cardiology, European Interbalkan Medical Centre, Thessaloniki, Greece.
Marcel AbrasUniversity Clinic of Interventional Cardiology, Nicolae Testemitanu State University of Medicine and Pharmacy from Republic of Moldova, Chişinău, Moldova.
Lionel LerouxMedico-Surgical Department of Valvulopathies, CHU De Bordaux, Pessac, France.
Eric Van BelleCHU Lille, Institut Cœur Poumon, Pôle Cardiovasculaire et Pulmonaire, ACTION Group, Inserm U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille, France.
Didier TchétchéDepartment of Interventional Cardiology, Clinique Pasteur, Toulouse, France.
Sabine BleizifferDepartment of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center North Rhine-Westphalia, Bad Oeynhausen, Germany.
Martin J SwaansDepartment of Cardiology, St. Antonius Hospital, Nieuwegein, Netherlands.
Radoslaw ParmaDepartment of Cardiology and Structural Heart Diseases, 3 Division of Cardiology, Medical University of Silesia, Katowice, Poland.
Daniel J BlackmanDepartment of Cardiology, Leeds Teaching Hospitals, Leeds, United Kingdom.
Nicolas M Van MieghemDepartment of Interventional Cardiology, Erasmus University Medical Center, Rotterdam, Netherlands.
Marek GrygierChair and 1st Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland.
Simon RedwoodDepartment of Cardiology, Guys and St Thomas' NHS Foundation Trust London, London, United Kingdom.
Bernard PrendergastDepartment of Cardiology, Guys and St Thomas' NHS Foundation Trust London, London, United Kingdom.
Guy Van CampDepartment of Cardiology, Heart Center OLV Aalst, Aalst, Belgium.
Ole De BackerHeart Center, Rigshospitalet, Copenhagen, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: A steep rise in the use of transcatheter aortic valve implantation (TAVI) for the management of symptomatic severe aortic stenosis occurred. Minimalist TAVI procedures and streamlined patient pathways within experienced Heart Valve Centres are designed to overcome the challenges of ever-increasing procedural volume. Aims: The 2022 European TAVI Pathway Survey aims to describe contemporary TAVI practice across Europe. Materials and methods: Between October and December 2022, TAVI operators from 32 European countries were invited to complete an online questionnaire regarding their current practice. Results: Responses were available from 147 TAVI centres in 26 countries. In 2021, the participating centres performed a total number of 27,223 TAVI procedures, with a mean of 185 TAVI cases per centre (median 138; IQR 77-194). Treatment strategies are usually (87%) discussed at a dedicated Heart Team meeting. Transfemoral TAVI is performed with local anaesthesia only (33%), with associated conscious sedation (60%), or under general anaesthesia (7%). Primary vascular access is percutaneous transfemoral (99%) with secondary radial access (52%). After uncomplicated TAVI, patients are transferred to a high-, medium-, or low-care unit in 28%, 52%, and 20% of cases, respectively. Time to discharge is day 1 (12%), day 2 (31%), day 3 (29%), or day 4 or more (28%). Conclusion: Reported adoption of minimalist TAVI techniques is common among European TAVI centres, but rates of next-day discharge remain low. This survey highlights the significant progress made in refining TAVI treatment and pathways in recent years and identifies possible areas for further improvement.

Indexed as

aortic stenosisearly dischargeminimalist TAVImultidisciplinary Heart TeamTranscatheter aortic valve implantation

Identifiers

PMID37645516
PMCPMC10461475

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.